David T. Weaver

12.4k total citations · 1 hit paper
150 papers, 9.0k citations indexed

About

David T. Weaver is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, David T. Weaver has authored 150 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 39 papers in Oncology and 29 papers in Genetics. Recurrent topics in David T. Weaver's work include DNA Repair Mechanisms (40 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Cancer-related Molecular Pathways (14 papers). David T. Weaver is often cited by papers focused on DNA Repair Mechanisms (40 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Cancer-related Molecular Pathways (14 papers). David T. Weaver collaborates with scholars based in United States, China and United Kingdom. David T. Weaver's co-authors include G. Todd Milne, Shengfang Jin, Melvin L. DePamphilis, Jonathan A. Pachter, Eric A. Hendrickson, György Hajnóczky, Irina M. Shapiro, David Baltimore, Xingguo Liu and Nikolai V. Boubnov and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

David T. Weaver

149 papers receiving 8.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

2016 754 citations Irina M. Shapiro, David T. Weaver et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David T. Weaver	6.5k	2.6k	1.4k	1.3k	865	150	9.0k
Bruno Amati	9.1k 1.4×	2.9k 1.1×	902 0.7×	1.4k 1.0×	772 0.9×	94	10.7k
Kentaro Semba	4.6k 0.7×	3.0k 1.1×	1.3k 0.9×	1.0k 0.8×	723 0.8×	143	7.8k
Bruno Calabretta	8.6k 1.3×	2.6k 1.0×	1.6k 1.2×	1.6k 1.2×	1.1k 1.2×	237	13.2k
Dirk Eick	8.9k 1.4×	2.6k 1.0×	968 0.7×	991 0.7×	713 0.8×	131	10.8k
Antonio Di Cristofano	6.7k 1.0×	2.1k 0.8×	1.2k 0.9×	1.5k 1.1×	827 1.0×	75	9.1k
Zhenkun Lou	6.8k 1.0×	2.8k 1.1×	989 0.7×	1.4k 1.1×	576 0.7×	134	9.0k
Eugenio Santos	5.8k 0.9×	2.2k 0.8×	802 0.6×	1.1k 0.8×	1.0k 1.2×	154	8.3k
Takumi Kamura	5.6k 0.9×	2.5k 1.0×	790 0.6×	1.5k 1.2×	965 1.1×	85	7.3k
Douglas C. Dean	8.4k 1.3×	4.6k 1.7×	1.4k 1.0×	1.9k 1.4×	1.2k 1.4×	107	11.9k
Jean Y. J. Wang	8.3k 1.3×	4.5k 1.7×	807 0.6×	1.2k 0.9×	886 1.0×	127	11.6k

Countries citing papers authored by David T. Weaver

Since Specialization

Citations

This map shows the geographic impact of David T. Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Weaver more than expected).

Fields of papers citing papers by David T. Weaver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Weaver. The network helps show where David T. Weaver may publish in the future.

Co-authorship network of co-authors of David T. Weaver

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Weaver. A scholar is included among the top collaborators of David T. Weaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Weaver. David T. Weaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Shih‐Shih, Jacqueline C. Barrientos, Gerardo Ferrer, et al.. (2023). Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model. Clinical Cancer Research. 29(10). 1984–1995. 5 indexed citations

Till, Kathleen J., Thomas A. Marks, Sílvia Coma, et al.. (2023). Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib. Scientific Reports. 13(1). 3793–3793. 5 indexed citations

Katona, Máté, Ádám Bartók, Zuzana Nichtová, et al.. (2022). Capture at the ER-mitochondrial contacts licenses IP3 receptors to stimulate local Ca2+ transfer and oxidative metabolism. Nature Communications. 13(1). 6779–6779. 57 indexed citations

Timbrell, S, Angela Cramer, David T. Weaver, et al.. (2021). FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity. npj Breast Cancer. 7(1). 65–65. 22 indexed citations

Davids, Matthew S., Bryone J. Kuss, Peter Hillmen, et al.. (2020). Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study. Clinical Cancer Research. 26(9). 2096–2103. 33 indexed citations

Wang, Xiangmeng, Po Yee Mak, Hong Mu, et al.. (2020). Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 19(8). 1636–1648. 13 indexed citations

Lamanna, Nicole, Árpád Illés, Gabriel Étienne, et al.. (2019). Effect of dose modifications on response to duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the DUO trial. American Journal of Hematology. 94. 1 indexed citations

Carter, Bing Z., Po Yee Mak, Xiangmeng Wang, et al.. (2017). Focal Adhesion Kinase as a Potential Target in AML and MDS. Molecular Cancer Therapeutics. 16(6). 1133–1144. 31 indexed citations

Horwitz, Steven M., Raphael Koch, Pierluigi Porcu, et al.. (2017). Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma. Blood. 131(8). 888–898. 204 indexed citations

10.

Kolev, Vihren N., Quentin G. Wright, Christian M. Vidal, et al.. (2014). PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells. Cancer Research. 75(2). 446–455. 116 indexed citations

11.

Nguyen, Tammy, Sang Su Oh, David T. Weaver, et al.. (2014). Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease. Proceedings of the National Academy of Sciences. 111(35). E3631–40. 171 indexed citations

12.

Fagerholm, Rainer, Kam Sprott, Tuomas Heikkinen, et al.. (2013). Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer. Annals of Oncology. 24(11). 2780–2785. 27 indexed citations

13.

Vaezi, Alec, Shama Buch, William E. Gooding, et al.. (2011). XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research. 17(16). 5513–5522. 42 indexed citations

14.

Alexander, Brian M., Kam Sprott, XiaoZhe Wang, et al.. (2010). DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer. Clinical Cancer Research. 16(23). 5796–5804. 27 indexed citations

15.

Huang, Jin, Jianxin Shi, Virginie Molle, et al.. (2005). Cross-regulation among disparate antibiotic biosynthetic pathways of Streptomyces coelicolor.. HAL (Le Centre pour la Communication Scientifique Directe). 4 indexed citations

16.

L’Heureux, Alexandre, Alain Martel, Huan He, et al.. (2004). (S,E)-N-[1-(3-Heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activity. Bioorganic & Medicinal Chemistry Letters. 15(2). 363–366. 6 indexed citations

17.

Bharti, Ajit, Stine‐Kathrein Kraeft, Mrinal M. Gounder, et al.. (1998). Inactivation of DNA-Dependent Protein Kinase by Protein Kinase Cδ: Implications for Apoptosis. Molecular and Cellular Biology. 18(11). 6719–6728. 188 indexed citations

18.

Weaver, David T.. (1995). V(D)J Recombination and Double-Strand Break Repair. Advances in immunology. 58. 29–85. 51 indexed citations

19.

Staunton, Jane & David T. Weaver. (1994). seid Cells Efficiently Integrate Hairpin and Linear DNA Substrates. Molecular and Cellular Biology. 14(6). 3876–3883. 17 indexed citations

20.

Hendrickson, Eric A., et al.. (1991). Strand Breaks without DNA Rearrangement in V(D)J Recombination. Molecular and Cellular Biology. 11(6). 3155–3162. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact